Compugen (CGEN) - P/S ratio

P/S ratio as of July 2026 (TTM): 3.24

According to Compugen's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.47. At the end of 2026 the company had a P/S ratio of 2.67.

P/S ratio history for Compugen from 2001 to 2026

PS ratio at the end of each year

Year	P/S ratio	Change
2026	2.67	32.98%
2025	2.01	-60.25%
2024	5.04	-3.48%
2023	5.23	-36.87%
2022	8.28	-86.15%
2021	59.8	-88.06%
2020	501
2019	N/A	-100%
2018	7.56
2017	N/A	-100%
2016	366	972.79%
2015	34.1	0.48%
2014	34.0	-66.33%
2013	101	-86.52%
2012	749
2011	N/A	-100%
2010	171	-73.26%
2009	638	1657.87%
2008	36.3	-84.39%
2007	232	-1.23%
2006	235	467.05%
2005	41.5	17.02%
2004	35.5	130.82%
2003	15.4	266.99%
2002	4.19	-61.18%
2001	10.8

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Seagen SGEN	18.8	478.74%	🇺🇸 USA
Genetic Technologies GENE	0.2168	-93.31%	🇦🇺 Australia
Teva Pharmaceutical Industries TEVA	2.10	-35.08%	🇮🇱 Israel
Eterna Therapeutics ERNA	N/A	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Compugen (CGEN)

P/S ratio as of July 2026 (TTM): 3.24